16

Oct2020
After much anticipation, the issuance of the PMPRB Guidelines has been delayed. The revised date of publication is uncertain at this time. Due to this announcement, PDCI will be postponing its webinar focused on the final guidelines originally scheduled for Tuesday, October 20, 2020. Additional information will ... Read More

30

Sep2020
Over the last few months, PDCI Market Access Inc., Connex Health and H3 Consulting have undertaken an initiative to better understand the Canadian private payer product listing agreement (PLA) landscape and how it has evolved ... Read More

25

Sep2020
At PDCI Market Access Inc., our vision at PDCI is to be your most trusted and valued pricing and reimbursement strategic partner. To ensure we continue to meet the strategic needs of our customers in the face of the ever-changing Canadian reimbursement landscape, we’ve expanded our Health Economic ... Read More

10

Sep2020
PDCI Market Access is pleased to release our premier issue of PDCI Market Access INSIGHTS online journal to our Market Access Toolkit subscribers. The articles in our first issue provide deep dives into: Planning and budgeting PSPs during the pandemic,New data and new perspectives on private insurers and ... Read More

19

Aug2020
PDCI is pleased to announce the release of the 2020 update to the PDCI Census of Insurers. The PDCI Census of Insurers is available exclusively through the PDCI Market Access Toolkit.  PDCI’s Census of Insurers estimates the market share and private covered lives by insurer across ... Read More

04

Aug2020
In June 2020, PMPRB launched a public consultation on its new draft Guidelines as a next step towards implementing the recently amended Patented Medicines Regulations. The deadline to submit written feedback is today,August 4, 2020. Details on submitting a consultation response can be found on the PMPRB ... Read More

13

Jul2020
ALERT! PMPRB WEBINAR RESCHEDULED Given all the new information this week, as well as the consultation extension, PDCI is postponing its PMPRB webinar.  Our second free webinar for industry will now be held on July 22, 2020 between 10:30 am – 12:00 ... Read More

02

Jul2020
Request-for-Reconsideration-To-CADTHDownload

30

Jun2020
CADTH’s Pharmaceutical Reviews Updates are used to communicate new Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) drug review process updates to the public. PDCI has outlined below the key highlights from the most recent update. For more information, please consult the CADTH ... Read More

20

Jun2020
As PDCI announced earlier today, the PMPRB has issued the second draft of the PMPRB Guidelines to support the implementation of Patented Medicines Regulations (Regulations) changes coming unto force on January 1, 2021.  This draft is now available for a 30-day Notice and Comment Period.  Written feedback ... Read More